2 transcripts
MDGL
Earnings call transcript
NASDAQ
2024 Q3
31 Oct 24
get closer to launch, we're going to come back and give a little bit more of an assessment of what do patient numbers look like, exactly who the targets
MDGL
Earnings call transcript
NASDAQ
2024 Q1
7 May 24
approximately 700 F4 patients with a composite primary endpoint that assesses conversion to decompensated cirrhosis. There is an even higher urgency
- Prev
- 1
- Next